Toxoplasma gondii infection is one of the most frequent parasitic infections of humans. This parasite is present in the brain of an estimated two billion people–about 40 percent of all humans on earth. It is endemic throughout the world, causing water…
Author: The Medical News
Oxidative stress and growth factors associated with development of high myopia
According to the first world report on vision published by the WHO in 2019, a third of the planet’s population suffers from myopia, and around 400 million people suffer the most harmful version of the disease: high myopia.
Microperimetry can help determine the efficacy of novel treatments for macular diseases
Stargardt disease is an inherited eye disease. Its onset is typically in adolescence and it is among the leading causes of blindness in this age group. Symptoms range from severe loss of sharp vision to almost complete loss of sight.
Stem cell model sheds new light on the devastating process of neurodegeneration
A new study published today in Neuron led by The New York Stem Cell Foundation (NYSCF) Research Institute’s Valentina Fossati, Ph.D., creates astrocytes – an integral support cell in the brain – from stem cells and shows that in disease-like environmen…
Inexpensive screening method for retinal changes in diabetics
Retinal damage due to diabetes is now considered the most common cause of blindness in working-age adults.
Santen’s VEKTIS study demonstrates efficacy and tolerability of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivis, over 12 months
Santen EMEA is delighted to announce that the results of VEKTIS, a twelve month study in pediatric vernal keratoconjunctivitis have been published in the American Journal of Ophthalmology.
Santen appoints Dr Sophia Pathai as new Vice President of Medical Affairs EMEA
Santen is proud to announce and welcome Dr Sophia Pathai (MBBS, PhD, MSc MRCOphth, MFPM) as the new Vice President (VP) of Medical Affairs EMEA.
IOB director wins Greenberg Prize for ending blindness by 2020
Professor Botond Roska, Director at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and Professor at the University of Basel, Faculty of Medicine and Faculty of Science, has won the Sanford and Susan Greenberg Visionary Prize “for uni…
New textile coating prevents viruses from adhering to the surface
Masks, gowns, and other personal protective equipment (PPE) are essential for protecting healthcare workers. However, the textiles and materials used in such items can absorb and carry viruses and bacteria, inadvertently spreading the disease the weare…
New study to evaluate drug combination treatment for uveitis
Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evalu…
U.S. physician survey highlights impact and burden of Thyroid Eye Disease on patients’ quality of life
Horizon Therapeutics plc today announced results of a U.S. physician survey showing that endocrinologists and ophthalmologists perceive Thyroid Eye Disease to have a significant burden on their patients’ quality of life.
A comprehensive analysis of evidence-based information to help manage myopia
A new literature analysis published in Ophthalmic & Physiological Optics, the peer-reviewed journal of The College of Optometrists, gives eye care practitioners (ECPs) a comprehensive analysis of evidence-based information needed to help manage myopia.
SARS-CoV-2 could spread through surface of the eyes
Researchers from Johns Hopkins University School of Medicine have found that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus could spread via ocular or eye surfaces. This is because the receptor where the virus binds – the ACE2, …
Scientists identify unexpected player that causes vision loss in patients with AMD
Scientists have identified an unexpected player in the immune reaction gone awry that causes vision loss in patients with age-related macular degeneration (AMD), according to a new study published today in eLife.
Researchers discover gene variants that reduce the risk of glaucoma
An international research collaboration led by researchers from the University of Helsinki and Stanford University has identified rare changes in a gene called ANGPTL7 that lower intraocular pressure and significantly reduce the risk of glaucoma
AI-based technology could help accelerate clinical trials for glaucoma
The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials, and eventually may be used in detection and diagnostics, according to the Wellcome-funded study published today in Expert Review of Molecular…
Glasses to stop progression of myopia shown to work in multi-site trial
Glasses to stop myopia or nearsightedness in children have been shown to work in a multi-site trial of 256 children and will go on sale later this year outside the United States.
Researchers test clinical safety of gene-based treatment for achromatopsia
People with complete color blindness are born unable to distinguish colors. They see less sharply and are highly sensitivity to glare.
New potential treatment candidate identified for early type 2 diabetic retinopathy
Diabetic retinopathy is one of the main vascular complications of type 2 diabetes, and the most common cause of visual deterioration in adults.
A new test for rapid large-scale testing of COVID-19
OU Medicine, the OU Health Sciences Center and the Oklahoma Medical Research Foundation collaborated to create a new test for COVID-19 using technology and reagents from Fluidigm Corporation, an innovative biotechnology tools provider